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LSD1 and LSD2 are homologous histone demethy-
lases with opposite biological outcomes related to
chromatin silencing and transcription elongation,
respectively. Unlike LSD1, LSD2 nucleosome-deme-
thylase activity relies on a specific linker peptide
from the multidomain protein NPAC. We used sin-
gle-particle cryoelectron microscopy (cryo-EM), in
combination with kinetic and mutational analysis, to
analyze the mechanisms underlying the function of
the human LSD2/NPAC-linker/nucleosome complex.
Weak interactions between LSD2 and DNA enable
multiple binding modes for the association of the
demethylase to the nucleosome. The demethylase
thereby captures mono- and dimethyl Lys4 of the
H3 tail to afford histone demethylation. Our studies
also establish that the dehydrogenase domain of
NPAC serves as a catalytically inert oligomerization
module. While LSD1/CoREST forms a nucleosome
docking platform at silenced gene promoters,
LSD2/NPAC is a multifunctional enzyme complex
with flexible linkers, tailored for rapid chromatin
modification, in conjunction with the advance of the
RNA polymerase on actively transcribed genes.
INTRODUCTION
Nucleosomes are the tunable elements of chromatin. Multiple
signaling pathways converge to build histone post-transcrip-
tional modification patterns and in turn modulate the dynamics
of the nucleosome by either directly affecting nucleosome stabil-
ity or recruiting specific chromatin remodelers. NucleosomeThis is an open access article under the CC BY-Nassembly, disassembly, and modification are carried out by
enzymatic subunits embedded within large macromolecular
complexes (McGinty and Tan, 2015; Kim et al., 2019; Ricketts
et al., 2019; Zhou et al., 2019). The histone demethylases
LSD1 and LSD2 represent particularly important examples for
exploring fundamental molecular mechanisms underlying these
processes. These two enzymes share a highly homologous cat-
alytic domain and employ an identical flavin-dependent reaction
mechanism to process the same substrate: mono- and dimethyl
Lys4 of histone H3 (H3K4me1 and H3K4me2) (Fang et al., 2013;
Forneris et al., 2005; Karytinos et al., 2009; Lee et al., 2005; Shi
et al., 2004). Despite their similar catalytic cores, LSD1 and LSD2
feature distinct non-catalytic domains, which form distinguish-
able binding platforms for different partners and accessory sub-
units. The elongated tower domain of LSD1 is bound tightly to
CoREST (co-repressor of RE1 silencing transcription factor
[REST]), which is necessary to grasp the histone tail from DNA
(Kim et al., 2015; Pilotto et al., 2015). LSD1/CoREST also forms
a bifunctional complex with histone deacetylases (HDAC1 and
HDAC2) to establish chromatin repression at gene promoters
(Marabelli et al., 2016; Shi et al., 2004). In contrast, LSD2 does
not interact with HDACs andCoREST (Chen et al., 2013; Ciccone
et al., 2009; Fang et al., 2010, 2013; Nagaoka et al., 2015; Zhang
et al., 2013). The biological partner of LSD2 is NPAC (a cytokine-
like nuclear factor, also named GLYR1 or NP60), a multidomain
protein comprising an N-terminal PWWP domain and a
conserved C-terminal dehydrogenase domain (Figure 1A). The
two are connected by a long stretch of roughly 170 residues
comprising two protein-protein interaction motifs. An AT-hook
module (residues 168–180) that binds and activates the
mitogen-activated protein kinase (MAPK) p38a is followed by a
linker segment (residues 214–225) that binds LSD2 with sub-
micromolar affinity (Figure 1A; Fang et al., 2013; Fu et al.,
2006). This short NPAC segment was shown to stimulate




Figure 1. NPAC Linker Sustains Productive Nucleosome Recognition by LSD2
(A) Domain organization of LSD2 and NPAC. Disordered regions are in wavy lines. LSD2 (PDB: 4hsu) is colored according to its multidomain architecture, with the
flavin adenine dinucleotide (FAD) in gold and the zinc ions in light blue.
(B) Our semisynthetic nucleosomes form a covalent adduct with the FAD of LSD2 (absorbance peak at 400 nm rather than at 458 nm, as for the oxidized enzyme).
(C) Elution profile (WTC-030S5 column, Wyatt) of semisynthetic NCP (10 mM) and LSD2 (20 mM) after 1 h of incubation with or without the NPAC linker (100 mM).
Respectively, 2:2:1 and 1:1:1 stand for (LSD2/NPAC-linker)2/NCP and LSD2/NPAC-linker/NCP complexes. See also Figure S1.
(D) Elution profile of the LSD2/NPAC-linker/NCP sample used for cryo-EM (dashed lines; three 10/300 columns of Superdex 200 in series, GE Healthcare).
Protein, DNA, and the flavin-H3 covalent adduct were detected by monitoring the absorbance at 280, 260, and 400 nm, respectively.
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hydrophobic groove between the amine oxidase and the SWIRM
domains of the demethylase (Figure 1A; Chen et al., 2013; Fang
et al., 2013).
Several studies consistently demonstrate that both LSD2
and NPAC localize within trimethylated Lys36 of histone H3
(H3K36me3)-rich chromatin regions of actively transcribed
gene bodies (Fang et al., 2010; Fei et al., 2018; Vermeulen
et al., 2010). Depletion of either LSD2 or NPAC leads to similar
inhibitory effects on gene transcription elongation (Fang et al.,
2010; Fei et al., 2018). This seems to indicate that the LSD2/
NPAC system processes chromatin before the passage of the
RNA polymerase II (Pol II) elongating complex along DNA.
Consistent with this hypothesis, the H3K4me2 signal decreases
downstream of Pol II, and it is reconstituted immediately up-
stream (Barski et al., 2007). However, it remains elusive how a
repressive epigenetic signal such as H3K4 demethylation would
be important for transcriptional elongation.
The LSD2/NPAC complex represents a canonical example
of chromatin regulation by the interplay between catalytic and
non-catalytic modules within a single multisubunit nucleo-
some-modifying complex, but numerous fundamental questions
remain to be answered.What is the role of the characteristic non-
catalytic domains of LSD2? Do they promote the engagement
of the histone tail within the active site? How does the short linker
sequence of NPAC stimulate nucleosome demethylation? What
is the role of DNA and the histone octamer in substrate recogni-
tion? Above all, how do the different architectures of LSD1/
CoREST and LSD2/NPAC give rise to their opposing biological
outcomes: gene repression by LSD1 versus transcriptional acti-
vation by LSD2? Here, we addressed these questions by cryoe-
lectron microscopy (cryo-EM) analysis of the structure and
conformational plasticity of the LSD2/nucleosome complex, as
well as by dissection of the molecular properties of the multido-
main protein NPAC. Our studies lead to the unexpected conclu-
sion that instead of being a nucleosome-docking unit like LSD1/
CoREST, LSD2/NPAC is a multimeric enzyme complex exqui-
sitely tailored for the efficient processing of nucleosomal histone
tails.
RESULTS AND DISCUSSION
H3K4me1 and H3K4me2 Demethylation Is More
Efficient with Longer H3-Tail Peptides but Not Affected
by the NPAC Linker
Our first experiments aimed to dissect the binding and kinetics
of the human LSD2 demethylase reaction using the recombi-
nant human enzyme expressed in Pichia pastoris and several
mono- and dimethylated H3 N-terminal peptides (Table 1).
First, we confirmed the previously reported faster turnover
rates for H3K4me2 over H3K4me1 substrates (Table 1; Chen
et al., 2013). Second, we showed that increasing the lengths
of the H3 peptides improves LSD2 catalytic efficiency, with
as much as an 8-fold lower KM for the dimethylated 40-residue
over the 21-residue substrate. Third, the enzymatic activity
was markedly affected by the ionic strength: at 100 mM
NaCl, KM for the H31–21 peptide is 8–10 times higher
compared to the value measured in the absence of salt. This
effect was less pronounced on the longer H31–40 peptides,for which an increase in KM was only detectable at 200 mM
NaCl (Table 1).
These data indicated that residues 20–40 of the H3 tail
feature improved catalytic activity. To investigate their actual
contribution to binding, we studied a charge-removing double
mutation, targeting two Lys residues in the 21- to 30-residue
segment. We found that the K23M-K27M H31–40 peptide is as
effective as a substrate as the wild type. Moreover, we tested
LSD2 activity at 100 mM NaCl in the presence of 100 mM
H316–40 or H321–40 peptides. No inhibition was observed, indi-
cating that the standalone H316–40 and H321–40 segments
bind, at best, too weakly to hamper substrate recognition by
LSD2 (Table 1). These findings highlight residues 1–20 as the
main drivers of H3-tail binding to the demethylase, with the
subsequent amino acids enhancing binding, especially under
conditions of high ionic strength.
Next, we studied how H3 peptide demethylation is affected
and potentially regulated by the NPAC linker (residues 214–225
of NPAC) (Figure 1A; Fang et al., 2013). The outcome of these
studies was consistent: the NPAC linker barely influences the
steady-state kinetics of H3 peptide binding and demethylation.
The only noticeable effect was that NPAC tends to mitigate the
worsening (increasing) of peptide KM values at high NaCl con-
centrations (150–200 mM) (Table 1).
NPAC Sustains Productive Nucleosome Recognition
by LSD2
To focus on the recognition and demethylation mechanisms of
the nucleosome, we reconstituted semisynthetic nucleosome
core particles (NCPs) with a chemically modified recombinant
H3 K4C-C110A double mutant exposing a propargylic group
instead of the physiological dimethyl Lys4 side chain (Pilotto
et al., 2015). These semisynthetic NCPs function as a suicide
substrate: their H3 tail assumes a catalytically competent
conformation within the enzyme active pocket and thereby cova-
lently attacks the flavin prosthetic group (Figure 1B). Formation
of the covalent NCP/demethylase complex can be easily visual-
ized and quantified by analytical size-exclusion chromatography
(Figure 1C).
Incubation trials with LSD2 and the semisynthetic NCPs re-
sulted in poor, albeit clearly detectable, LSD2/NCP complex
formation, but the addition of the NPAC-linker peptide led to
a marked 7-fold increase in formation of the complex (Fig-
ure 1C). This value matches the reported NPAC effect on
nucleosome demethylation by LSD2 as measured by pub-
lished western blot assays (Chen et al., 2013; Fang et al.,
2013). We systematically observed the presence of two
peaks in the chromatograms. Based on their elution volumes
and DNA content, gathered by the relative absorbance at
260 nm, we attributed the major peak to a 1:1:1 LSD2/
NPAC-linker/NCP complex and the minor peak to a 2:2:1
complex (i.e., one LSD2/NPAC bound to each H3 of the
same NCP). Neither varying the ionic strength nor performing
charge-removing mutations of H3 (K23M-K27M) affected
nucleosome binding with or without the NPAC linker (Fig-
ure S1). Therefore, our semisynthetic NCPs proved to be
effective, useful tools for studying nucleosome recognition
by LSD2 and the activating role of NPAC.Cell Reports 27, 387–399, April 9, 2019 389
Table 1. H3K4me1 and H3K4me2 Demethylation Is More Efficient with Longer H3-Tail Peptides but Not Affected by the NPAC Linker
Monomethyl Lys4a Dimethyl Lys4a
NPACb NaCl (mM) 1–21 1–30 1–21 1–30 1–40 1–40 K23M K27M 1–40 + DNAd
KM (mM)  0 5.89 ± 0.69 1.34 ± 0.13 1.91 ± 0.18 2.90 ± 0.27 0.99 ± 0.07 0.89 ± 0.05 no activity
+ 0 6.20 ± 0.69 1.18 ± 0.15 2.11 ± 0.19 1.85 ± 0.25 1.09 ± 0.06 0.68 ± 0.08 no activity
 50 ND ND ND ND ND ND 46.02 ± 7.44
+ 50 ND ND ND ND ND ND >80.00
 100 >60.00 5.11 ± 0.79 16.93 ± 3.08 6.18 ± 0.63 2.06 ± 0.25 2.51 ± 0.42 7.00 ± 0.87
+ 100 >60.00 2.36 ± 0.21 16.29 ± 3.59 6.04 ± 0.93 1.55 ± 0.12 1.02 ± 0.11 6.24 ± 0.62
 150 ND ND ND 13.50 ± 1.54 3.22 ± 0.35 ND ND
+ 150 ND ND ND 8.15 ± 1.11 2.03 ± 0.18 ND ND
 200 ND ND ND ND 6.46 ± 0.58 ND ND
+ 200 ND ND ND ND 4.94 ± 0.65 ND ND
kcat (min
1)  0 0.44 ± 0.01 0.56 ± 0.01 1.01 ± 0.02 1.39 ± 0.03 1.30 ± 0.02 1.24 ± 0.20 no activity
+ 0 0.66 ± 0.02 0.48 ± 0.01 1.02 ± 0.02 1.15 ± 0.04 1.18 ± 0.02 1.04 ± 0.02 no activity
 50 ND ND ND ND ND ND 1.84 ± 0.15
+ 50 ND ND ND ND ND ND 2.42 ± 0.38
 100 0.23 ± 0.02 0.41 ± 0.02 0.72 ± 0.05 1.46 ± 0.04 0.83 ± 0.03 0.92 ± 0.04 1.38 ± 0.06
+ 100 0.17 ± 0.03 0.34 ± 0.01 0.70 ± 0.06 1.30 ± 0.07 0.67 ± 0.01 0.64 ± 0.02 1.32 ± 0.04
 150 ND ND ND 1.01 ± 0.04 1.15 ± 0.03 ND ND
+ 150 ND ND ND 1.19 ± 0.05 1.05 ± 0.02 ND ND
 200 ND ND ND ND 1.23 ± 0.03 ND ND
+ 200 ND ND ND ND 1.39 ± 0.05 ND ND
Kd
c (mM)  0 ND ND 1.99 ± 0.30 ND ND ND ND
+ 0 ND ND 3.08 ± 0.38 ND ND ND ND
Data are represented as mean ± SEM. All assays were carried out with a peroxidase-coupled method. ND, not determined.
aThe number of amino acids of the histone H3 N-terminal peptide is indicated.
bNPAC-linker sequence 214–225 (Figure 1A).
cKd values were measured by fluorescence polarization using C-terminally tetramethylrhodamine (TAMRA)-labeled histone H3 peptide with sequence ARTKme2QTARKSTGGKAPRKQLA.






























DNA Interferes with LSD2 Catalysis
Collectively, the experiments with the H3 peptides and the intact
nucleosomal particles led to the surprising observations that
LSD2 is inhibited by the nucleosome and this inhibition is
rescued by the NPAC linker. To investigate the source of this
nucleosome-induced inhibitory effect on histone demethylation
by LSD2, we first established whether non-substrate histone
tails might compete with H3 for the LSD2 active site. We probed
the kinetics of peptide demethylation in the presence of high
concentrations (100 mM) of H2A1–19, H2A117–129, H2B4–19, or
H41–30 peptides. No inhibition was detected, suggesting that
the H2A, H2B, and H4 tails do not interfere with LSD2 enzymatic
activity (Figure S2). Given this result, we next assayed LSD2 in
the presence of the isolated 147-bp 601 Widom DNA to probe
its effect on catalysis. At low ionic strength (no NaCl added)
activity was hardly detectable in the presence of DNA, both
with and without the NPAC linker. The demethylase activity
was recovered at 100 mM NaCl, though with a significant
3-fold increase of KM with respect to the experiments performed
in the absence of DNA (Table 1). These findings lead to the
fundamental conclusion that a main source of the NCP-exerted
inhibition is DNA.
The notion that DNA forms an intrinsic obstacle to nucleosome
binding and modification is well documented, and it has been
generally ascribed to the pronounced charge density of DNA
(McGinty and Tan, 2015; St€utzer et al., 2016; Gatchalian et al.,
2017; Morrison et al., 2018; Weaver et al., 2018). With reference
to LSD2, this phenomenon is functionally crucial, because it is
at the heart of the regulatory effect exerted by NPAC. The spe-
cific electrostatic interactions between the N-terminal, highly
charged, 15 amino acids of H3 and the inner catalytic pocket
of the demethylase are inevitably weakened or even compro-
mised by the contiguous crowded-with-charge nucleosomal
DNA (Table 1). Conversely, the binding of the H316–26 segment
to the outer active-site region of the LSD2/NPAC-linker complex
depends less on charged groups (see Table 1 and the K23M-
K27M mutation in Figure S1C). Instead, the binding of the
H316–26 segment to the LSD2/NPAC-linker complex involves
several hydrophobic contacts, especially with Phe217 of NPAC
(Figure 1A; Chen et al., 2013; Fang et al., 2013). These interac-
tions are expected to become increasingly more relevant at
higher ionic strengths, closer to the physiological conditions, en-
forcing the influence of NPAC on the LSD2 demethylase activity
(Table 1). This NPAC dependency is fully exhibited in the nucle-
osomal microenvironment, where not only the availability but
also conformational flexibility of the tail is limited by the neigh-
boring DNA (Morrison et al., 2018; Weaver et al., 2018).
Single-Particle Cryo-EM Reveals that Multiple
Conformations and Few Interactions Characterize the
LSD2/NPAC/NCP Complex
To structurally describe the mechanism of nucleosome binding
by LSD2/NPAC, we carried out single-particle cryo-EM. We
initially employed the semisynthetic nucleosomes reconstituted
with the 167-bp 601 Widom sequence that comprises the DNA-
linker segments, but the resulting LSD2/NPAC-linker/nucleo-
some complex could not be separated from the unbound
nucleosomes. The semisynthetic NCPs reconstituted with the147-bp 601 DNA gave excellent chromatographic profiles
and enabled the preparative milligram-quantity purification of
the covalent LSD2/NPAC-linker/NCP complex (Figure 1D).
The specific cross-linking between the LSD2 flavin and the
modified H3K4 enabled the purification of an otherwise inher-
ently short-lived enzyme-substrate complex, without the need
for external cross-linking agents (Figure 1B). The cryo-EM anal-
ysis revealed five distinct structures, and three of them (classes
2–4) correspond to clearly defined LSD2/nucleosome com-
plexes (Figure 2). The demethylase region of the map is always
less resolved, suggesting local variability of the LSD2 orienta-
tion, but the structures are still fully interpretable (Figures S3
and S4).
In class 2, the body of LSD2 arches over the nucleosome dyad
(Figure 2A). The contacts between LSD2 and NCP are confined
to two small areas (Figure 3A). In the first one, the H3-tail-binding
loop (residues 478–482) of the LSD2 amine oxidase domain con-
tacts the two base pairs of the nucleosomal DNA entry-exit point.
In the second contact region, a loop on the C4H2C2 domain of
LSD2 (residues 101–107) interacts with a short segment of the
H3 a1 helix (around Glu73) and the N-terminal tail of H4 (around
Asp24). The trace of the H3 N-terminal segment between the
LSD2 catalytic pocket and the nucleosome exit point cannot
be revealed at the resolution of our density maps. However,
structural analysis predicts that both H3 histones of the NCP
can be engaged by LSD2. The first possibility is in line with the
LSD2/NPAC-linker/H31–26 co-crystal structure: residues 23–35
of H3 extend over a distance of 33 A˚ from the rim of the
LSD2 catalytic cleft to the site where the tail protrudes from
the nucleosome (dashed in Figure 3A, middle). The second pos-
sibility is that Met15 of H3, at the entrance of the LSD2 catalytic
pocket, is connected to Lys36, located at the nucleosomal exit
point that is closer to LSD2 amine oxidase (35-A˚ distance)
(dashed in Figure 3A, left).
In class 3, the L-shaped LSD2 arches over the edge of theNCP
and protrudes laterally from the nucleosomal disk (Figure 2A).
The single contact point between the demethylase and the
NCP involves a loop on the LSD2 linker region (residues 275–
280) and the nucleosomal DNA at the super-helical location
(SHL) ± 2 (Figure 3B). The distance covered by H3 from Met15
within the LSD2 active site to Lys36 in the NCP is 43 A˚, which
is compatible with multiple extended conformations of the tail
(dashed in Figure 3B, right).
From the inspection of the less well-defined class 4map, it can
be inferred that LSD2 sits tangentially to the NCP disk in prox-
imity of the SHL ± 6 (Figure 2A). The putative contact areas on
the NCP comprise a few nucleotides, together with residues
from H2A (a2 and a3 helices) and H2B (loop a1–a2), close to
the acidic patch (Figure 3C).
Despite their strikingly different binding configurations, the
LSD2/NPAC-linker/NCP structures share a few insightful fea-
tures. In all cases, the demethylase-NCP contacts are confined
to a few amino acids and nucleotides and there is no extensive
interacting surface between the two components. Furthermore,
the H3 segment linking the LSD2 active site to the NCP core—
from Met15 to Lys36—is always predicted to follow trajectories
running along the DNA grooves. Consistently, these trajectories
fall within the ensembles of nucleosomal H3-tail conformationsCell Reports 27, 387–399, April 9, 2019 391
(legend on next page)
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Figure 3. Close-Up Views of LSD2/NCP Interfaces
(A) Class 2 features two contact points between the LSD2 and the nucleosome, depicted in the close-up views.
(B) Class 3 displays a single contact point.
(C) Contact region (in cyan) of class 4 involves DNA super-helical location ± 6 and two short segments of H2A andH2B. Colors are the same as in Figure 2, with the
NPAC linker in violet. The density maps are depicted as light gray mesh. Reference residues are labeled, and their Ca atoms are shown as spheres. Dashed lines
highlight possible pathways of H3 tails connecting the NCP to the LSD2 catalytic site. See also Figures S3 and S4.revealed by NMR and computational studies (Morrison et al.,
2018). These findings demonstrate that the flexibility of the H3
tail enables multiple and catalytically active binding poses with
limited contacts between the LSD2 and the nucleosomal main
body.
The cryo-EM analysis revealed two other classes comprising
isolated NCPs, though in different states. Class 1 contains
roughly half of the particle images and corresponds to the
isolated and fully assembled NCP at an overall resolution of
4.02 A˚ (Figures 2B, S3, and S4). Class 5 represents a hexasome,
with its visible protruding DNA. The density map for this class
shows that one H2A-H2B dimer is missing and, on the side of
the nucleosome where DNA slipped away, the N-terminal a helix
of H3 is unfolded (Figures 2C, S3, and S4). The histone-DNA par-
ticle featured by class 5 was described previously as a state of
nucleosome dynamics and/or unfolding (Bilokapic et al., 2018).
Therefore, the same cryo-EM grid allowed us to visualize a partly
unfolded NCP, a fully folded particle, and three LSD2 complexes
in different conformations.Figure 2. Single-Particle Cryo-EM Reveals that Multiple Conformatio
Complex
The quality of the density maps can be best appreciated at the left, whereas mod
dark gray, light gray, purple, and pink, respectively. LSD2 (PDB: 4hsu) is in light b
DNAmolecule is entirely visible in all maps. The first and the last three base pairs w
(A) Overview of the three classes of the LSD2/NPAC-linker/NCP complex. For cl
(B) Class 1 represents the intact NCP, whereas class 5 is a partly unfolded NCPLSD2 Engages the DNA Template via Electrostatic
Interactions
Inspection of the LSD2 protein surface outlines several clusters
of positively charged side chains, mostly localized on the zinc-
finger domain and in contact with DNA, as shown by the cryo-
EM three-dimensional structures (Figures 4A and 4B). To inves-
tigate the specificity and magnitude of these interactions, we
carried out fluorescence polarization experiments with a 21-bp
oligonucleotide. At low ionic strength, full-length LSD2 exhibited
nanomolar affinity for DNA, whereas at 100 mM NaCl, the condi-
tion used for cryo-EM sample preparation and binding studies,
the affinity became barely detectable (Figure 4C; Table S1). To
gain more insights into DNA binding by LSD2, we mutated nine
Arg and Lys residues that are part of the class 2 and class 3
LSD2/NCP interactions (Figures 4A and 4B), aswell as two highly
charged disordered segments (the N-terminal 30 residues and
the conserved loop 241–258 at the rim of the H3-binding cleft)
(Figure 1A). The mutations did not affect DNA binding, with
the exception of the N-terminal D30 variant, which featured ans and Few Interactions Characterize the LSD2/NPAC-Linker/NCP
el fitting can be best visualized at the right. H2A, H2B, H3, and H4 are shown in
lue. The NCP structure used for map fitting was obtained from PDB: 6esf. The
ere modified to match our 601 sequence exactly. See also Figures S3 and S4.
ass 4, LSD2 is tentatively fitted at the left, simply as a reference.
: a H2A-H2B dimer is missing, and the N-terminal helix of H3 is unstructured.
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Figure 4. LSD2 Engages the DNA Template via Electrostatic Interactions
(A) The electrostatic surface of LSD2 exposed toward the nucleosome. Positively charged patches characterize the zinc-finger domain and part of the area
surrounding the H31–16-binding pocket. The bar indicates the electrostatic potential in kcal/mol*e. Red represents negative electrostatic potential while blue
represents positive charge potential.
(B) Close-up views of the LSD2-nucleosome interfaces in class 2 (middle) and class 3 (right), highlighting the LSD2 residues subjected to mutagenesis (red
spheres at Ca atoms).
(C) Effect of ionic strength on the binding affinities of full-length andD30 LSD2 toDNA. Changes in the fluorescence polarization weremeasured inmillipolarization
(mP) units and plotted against LSD2 concentrations. Error bars refer to experiments carried out in triplicate. Data are represented as mean ± SEM. See also
Table S1.
(D) Qualitative evaluation of LSD2mutations on LSD2/NPAC-linker/NCP complex yield. The histogram shows the ratio of the LSD2/NPAC-linker/NCP peak to the
absorbance of the free NCP peak (both recorded at 260 nm). The ratios are reported as percentages with reference to LSD2 wild type, which was given the
100% value.10-fold decrease in affinity (Figure 4C; Table S1). We also found
that all mutants bind NCP without drastic alteration in their effi-
ciency with respect to wild-type protein (Figure 4D). These
data corroborate the structural findings: LSD2 can weakly bind
DNA through salt-sensitive electrostatic interactions. This asso-
ciation is likely brought about by various positively charged
patches and does not depend on any specific cluster of residues
and/or specific binding geometry.
The PWWPDomain of NPAC Is a H3 Reader and Strongly
Binds DNA
In addition to the short LSD2-stimulating linker sequence, NPAC
comprises several domains whose molecular functions remain
poorly defined (Figure 1A). The NPAC N-terminal PWWPmodule
is homologous to other known H3K36me3 binders (Qin and Min,
2014), in agreement with the NPAC localization at H3K36me3
chromatin loci (Vermeulen et al., 2010). However, NPAC has
been shown to bind nucleosomes both with and without specific
epigenetic marks (Fei et al., 2018; Sankaran et al., 2016). To
determine whether the NPAC PWWP domain is a genuine his-
tone reader, we used the SPOT-peptide array technology, em-394 Cell Reports 27, 387–399, April 9, 2019ploying a large library of epigenetically modified H3 and H4 pep-
tides (Table S2). We observed a clear selectivity toward peptides
containing residues 35–40 of H3, without an evident preference
for specific epigenetic markers (Figure S5A). Consistent with
this result, isothermal calorimetry performed with the unmodified
H31–40 peptide yielded a Kd value of 30 mM (Figure S5B). The
unfavorable reduction of conformational entropy upon binding
is likely induced by the PWWP-guided partial folding of the
40-residue long peptide, in congruence with the previously char-
acterized PWWP domain-histone peptide interactions (Eidahl
et al., 2013; van Nuland et al., 2013). Bio-layer interferometry
experiments on H328–48 peptides confirmed the affinity for the
H3 C-terminal portion of the H3 tail, with no preference for the
methylation states of K36 (Figure S5C). Next, we explored
the capability of the NPAC PWWP domain to bind DNA.
Fluorescence polarization experiments revealed a strong—pri-
marily electrostatically driven—interaction, described by Kd =
0.68 mM at 100 mMNaCl (Figure S5D). Collectively, these obser-
vations highlight the PWWP of NPAC as a potent chromatin
binder with very high DNA affinity when compared to other pro-
teins of the same family (van Nuland et al., 2013; Weaver et al.,
Figure 5. NPAC Dehydrogenase Domain Is Catalytically Impaired and Forms a Stable Tetramer
(A) NPAC homolog sequences are aligned with two representative members of the short-chain alcohol-dehydrogenase family from Geobacter metallireducens
and G. sulfurreducens. The mutation of the catalytic lysine to methionine or asparagine is highlighted within a blue box.
(B) Crystal structure of the NPAC dehydrogenase domain (residues 261–553) shows a tetrameric assembly (PDB: 2uyy). The NADPH is visible in two subunits and
is in green. See also Figures S6 and S7 and Table S3. The inset shows the comparison between the active-site regions of the NPAC dehydrogenase (in salmon)
and those of the g-hydroxybutyrate dehydrogenase from G. sulfurreducens (PDB: 3pdu; gray).
(C) Elution profiles of wild-type, M437N, and M437K NPAC dehydrogenase domains (5/150 column; Superdex 200, GE Healthcare).2018; Wen et al., 2014). NPAC has been proposed to function as
a nucleosome-destabilizing factor (Fei et al., 2018). Given its
tight binding properties, the PWWP is likely responsible for this
activity. In the course of our experiments, the nucleosomes
tended to extensively precipitate upon mixing with the protein
domain, corroborating this hypothesis.
NPAC Dehydrogenase Domain Is a Catalytically Inert,
Tetramerization Module
The C-terminal domain of NPAC (residues 261–553) (Figures 1A
and 5A) belongs to the highly conserved family of b-hydroxy acid
dehydrogenases: cytosolic enzymes catalyzing the NAD+- or
NADP+-dependent oxidation of specific b-hydroxy acid sub-
strates (Njau et al., 2001; Zhang et al., 1999). Sequence homol-
ogy correlates the dehydrogenase domain of NPAC to glyoxylate
reductase. Despite featuring this fascinating topology for a chro-
matin protein, the function of the NPAC dehydrogenase domain
remains unknown. As part of our investigation of the LSD2/NPAC
system, we first confirmed that the protein tightly binds nicotin-
amide adenine dinucleotide phosphate (NADPH; Figure S6).Moreover, gel filtration and small-angle X-ray scattering (SAXS)
firmly demonstrated that the protein is tetrameric in solution (Fig-
ures 5B and S7; Table S3) (PDB: 2uyy). Therefore, the NPAC de-
hydrogenase domain is a tetrameric NADH- or NADPH-binding
protein that displays features typical of the b-hydroxy acid
dehydrogenases.
We observed that the NPAC dehydrogenase domain hosts a
methionine residue (Met437) in place of the highly conserved
and catalytically essential lysine shared by all b-hydroxy acid de-
hydrogenase enzymes (Figures 5A and 5B). This finding strongly
suggests that NPAC is catalytically inert, at least as a dehydroge-
nase enzyme. Consistently, a methionine or an asparagine at this
position is a conserved feature among all NPAC orthologs exhib-
iting the LSD2-binding linker sequence (Figure 5A). Along these
lines, we characterized two mutants: M437K and M437N. Sur-
prisingly, the M437K protein proved to be monomeric but aggre-
gation prone (Figure 5C) and far less stable than the wild
type (10C lower melting temperature). Conversely, the M437N
mutant retained the tetrameric arrangement and, upon addition
of NADPH, exhibited a thermostability value comparable toCell Reports 27, 387–399, April 9, 2019 395
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Figure 6. NPAC Tetramer Binds Multiple Copies of LSD2/Nucleosome
(A) NCP, LSD2, and NPACD205 (residues 206–553, containing the linker sequence and the dehydrogenase domain; see Figure 1A) were incubated at different
molar ratios as shown above each panel (NPACD205 concentrations refer to the tetramer, molecular weight [MW] = 151 kDa) (Table S3). Decreasing relative
amounts of NPACD205 with respect to nucleosome and LSD2 favors the formation of species at a higher molecular weight with greater DNA content (peak C), as
calculated from the A214/A260 ratio, which reflects the protein/DNA content. Peak A elutes at the same volume of the LSD2/NCP complex containing the NPAC
linker only (Ve = 2.35 mL). This peak, occasionally present in the chromatograms, is a species that has lost an intact NPACD205 (likely by proteolysis). The
experiments were performed on a WTC-030N5 column. See also Figure S7 and Table S3.
(B) Dehydrogenase domain of NPAC forms a stable tetramer decorated by flexible N-terminal arms, which comprise a PWWP domain, an AT-hook region
predicted to bind DNA, and the LSD2-activating segment.that of the wild-type protein. Combining these results, we
concluded that in the course of evolution, NPAC lost essential
catalytic elements but retained NADH or NADPH binding and
consolidated a stable tetrameric assembly. Therefore, the dehy-
drogenase domain has all features of a stable oligomerization
module.
LSD2/NPAC Is a Multimeric Complex
To broaden our understanding of LSD2/NPAC, we designed a
human NPAC variant that comprised both the LSD2-binding
linker and the C-terminal dehydrogenase domain (NPACD205)
(Figure 1A). This protein behaved as predicted: it was tetrameric
(SAXS data in Figure S7 and Table S3) and retained the ability to
bind LSD2 and sustain nucleosome recognition (Figure 6A).396 Cell Reports 27, 387–399, April 9, 2019These properties enabled the reconstitution of large complexes
involving LSD2, tetrameric NPAC, and NCP. With increasing
NCP and LSD2 relatively to the NPACD205 tetramer, a larger as-
sembly (peak C in the chromatogram of Figure 6A) was favored
over a minor yet conspicuous complex species (peak B), which
instead prevailed at higher NPACD205 concentrations. The
peak C complex featured higher DNA content than the peak B
species, as indicated by the DNA-to-protein absorbance ratios
(A214/A260). The large (0.5 MDa) size of these complexes was
confirmed by SAXS (Figure S7; Table S3). The interpretation of
these data is inherently challenging due to the complexity of a
system comprising multivalent binding species: the tetrameric
NPAC, the dimeric histone core of the nucleosome, and the
monomeric LSD2. Nevertheless, the chromatographic profiles,
DNA content analysis, and SAXS data convincingly converge
toward the idea that with increasing LSD2 and NCP concentra-
tions, multimeric assemblies form, containing multiple copies
of LSD2 and NCP per NPAC tetramer (Table S3).
CONCLUSIONS
The key finding of our work is that LSD2 and NPAC constitute a
multimeric system with a rigid core and flexible units. The N-ter-
minal portions of NPAC stretch out from the C-terminal stable
tetrameric core, evolved from an ancestral dehydrogenase
enzyme. Each of these flexible arms exposes two chromatin-
binding modules plus a chromatin-modifying enzyme. The AT
hook and the PWWP grasp the nucleosomal particles, possibly
increasing the avidity and processivity of neighboring LSD2
enzymes (Figure 6B). The positively charged surface patches
featured by LSD2, particularly by the zinc-finger domain, enable
its weak association with nucleosomal DNA. Such short-lived
encounter complexes drive the formation of the catalytically
productive LSD2/NPAC/nucleosome interactions that rely on
the NPAC-favored capture of the H3 tail by LSD2. This mode
of nucleosome recognition, together with the multimeric archi-
tecture of the complex, seems exquisitely suited for proces-
sive nucleosome modification, in association with the rapidly
advancing RNA polymerase on gene bodies.
It is instructive to compare these mechanistic features with
those described for LSD1, the other human flavin-dependent
histone demethylase. The overall architecture of LSD1/CoREST
is designed to stably clamp the nucleosomes at gene promoters
through tight interactions with both the H3 tail and the DNA
(Baron and Vellore, 2012; Kim et al., 2015; Pilotto et al., 2015).
This nucleosome-docking mode of operation clearly contrasts
with the tail-based mechanism of the multimeric and dynamic
LSD2/NPAC complex. LSD1 can thereby function to stably
induce repression at gene promoters, whereas LSD2 can more
dynamically operate to support active gene transcription by
the RNApolymerase. Given these contrasting features, it is fasci-
nating that both flavin-dependent systems rely on structurally
and mechanistically different auxiliary factors—CoREST and
NPAC—to overcome the same inhibitory histone tail-seques-
tering effect by nucleosomal DNA. Despite their different mech-
anistic strategies, multidomain architectures of the auxiliary
proteins, and opposing biological outcomes, these multiprotein
histone demethylase complexes are tailored to license their
enzymatic activities only on their appropriate target regions of
the chromatin.
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Tris(2-carboxyethyl)phosphine hydrochloride Sigma-Aldrich CAS: 51805-45-9
Isopropyl-b-D-thiogalactoside Sigma-Aldrich CAS:367-93-1
HEPES Sigma-Aldrich CAS: 7365-45-9
Dithiothreitol Sigma-Aldrich CAS: 3483-12-3
Peroxidase from horseradish Sigma Aldrich CAS:9003-99-0; Cat#P6782
Peptides used in binding and enzymatic assays China Peptides http://www.chinapeptides.com/english/
index.aspx
Ampliflu Red Sigma Aldrich CAS:119171-73-2; Cat#90101
SYPRO Orange Invitrogen Cat#S5692
H3 peptide used in ITC TUFTS http://tucf.tufts.edu/home/peptide_
synthesis
Critical Commercial Assays
SPOT-blot peptide interaction assay Picaud and Filippakopoulos, 2015 10.3390/microarrays4030370
Whatman Chromatography paper Grade 1CHR GE Healthcare Life Sciences Cat#3001-878
Horseradish peroxidase-conjugated anti-His antibody Novagen (Merck) Cat#71841
Pierce ECL Western Blotting Substrate Thermo Fisher Scientific Cat#32106




147 bp 601 nucleosome (class1) This paper EMDataResource: EMD-4704
PDB: 6R1T
LSD2/NPAC-linker (214-225)/nucleosome (class 2) This paper EMDataResource: EMD-4705
PDB: 6R1U
LSD2/NPAC-linker (214-225)/nucleosome (class 3) This paper EMDataResource: EMD-4710
PDB: 6R25
(Continued on next page)
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Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
LSD2/NPAC-linker (214-225)/nucleosome (class 4) This paper EMDataResource: EMD-4711
147 bp 601 nucleosome (class 5) This paper EMDataResource: EMD-4712
LSD2/NPAC-linker (214-225)/H3 (1-26) Fang et al., 2013 PDB: 4HSU
cytokine-like nuclear factor NPAC dehydrogenase
(261-553)
http://www.rcsb.org PDB: 2UYY
LSD2 D30 (31-822) This paper SASBDB: SASDFU3
nucleosome This paper SASBDB: SASDFX3
NPAC dehydrogenase (261-553) This paper SASBDB: SASDFV3
NPAC D205 (206-553) This paper SASBDB: SASDFW3
LSD2 D30 (31-822)/NPAC D205 (206-553)/
nucleosome
This paper SASBDB: SASDFY3
Oligonucleotides
TAMRA labeled 21-nt DNA Microsynth AG https://www.microsynth.ch/standard-
synthesis.html
Recombinant DNA
LSD2 and NPAC full-length human genes GeneArt https://www.thermofisher.com/us/en/
home/life-science/cloning/gene-synthesis/
gene-strings-dna-fragments.html
pJ902Express vector DNA 2.0 (now ATUM) https://www.atum.bio/catalog/expression-
vectors/yeast#CytoplasmicExpression2
NPAC 261-553 in pNIC28-Bsa4 vector SGC https://www.thesgc.org/
Software and Algorithms
Clustal Omega (EMBL-EBI) Li et al., 2015 https://www.ebi.ac.uk/Tools/msa/clustalo/
ESPript 3 Robert and Gouet, 2014 http://espript.ibcp.fr/ESPript/ESPript/
ELM Dinkel et al., 2016 http://elm.eu.org/
Uniprot Bateman et al., 2017 https://www.uniprot.org/
GraphPad Prismversion 6.00 for Windows GraphPad https://www.graphpad.com/
MicroCal Origin Origin https://www.originlab.com/
ForteBio analysis software V.9.0.014 ForteBio www.fortebio.com
CHROMIX Panjkovich and Svergun, 2018 https://www.embl-hamburg.de/biosaxs/
chromixs.html
ATSAS package Franke et al., 2017 https://www.embl-hamburg.de/biosaxs/
software.html
Scatter Fo¨rster et al., 2010 http://www.bioisis.net/tutorial/9
PRIMUS Konarev et al., 2004 https://www.embl-hamburg.de/biosaxs/
primus.html
cisTEM Grant et al., 2018 https://cistem.org/
MotionCor2 Zheng et al., 2017 http://msg.ucsf.edu/em/software/
motioncor2.html
Ctffind Rohou and Grigorieff, 2015 http://grigoriefflab.janelia.org/ctf
RELION Scheres, 2012 https://www3.mrc-lmb.cam.ac.uk/relion/
index.php?title=Main_Page
Coot Emsley and Cowtan, 2004 http://www2.mrc-lmb.cam.ac.uk/Personal/
pemsley/coot/
Chimera Pettersen et al., 2004 https://www.cgl.ucsf.edu/chimera/
Other
Carbon grids for cryo-EM Quantifoil https://www.emsdiasum.com/microscopy/
products/grids/quantifoil.aspx
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Andrea
Mattevi (andrea.mattevi@unipv.it).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Protein expression
All histone proteins were expressed in BL21(DE3) pLysS E.coli cells according to established protocols (Luger et al., 1997). LSD2 full-
length proteins were expressed in E. coli BL21(DE3). Cells were grown in LB medium supplemented with 100 mg/ml ampicillin under
shaking conditions till O.D.600nm = 0.8. Induction was performed with 0.5 mM IPTG and 0.1 mM ZnSO4 at 17
C for 18 hours. Cells
were collected by centrifugation at 5000 rpm for 10 minutes and stored at20C. LSD2D30-expressing P. pastoris cells were grown
in flasks at 30C under shaking conditions for 72 hours and induced with methanol for 48 hours. Cells were then collected by centri-
fugation at 4000 rpm for 10 minutes and stored at 20C. The PWWP domain (residues 1-105) was expressed in E. coli BL21(DE3).
Cells were grown in 2xYT medium supplemented with 100 mg/ml kanamycin and 1% (w/v) glucose at 37C until O.D.600 reached 1.
Induction was performedwith 0.1mM IPTG for 16 h at 17C. NPACD205 (linker + dehydrogenase) was expressed in E. coliBL21(DE3)
RPplus, and cells were induced by autoinducing protocol. Cells were collected by centrifugation at 5000 rpm for 10 minutes and
stored at 20C. NPAC dehydrogenase proteins were expressed in E. coli BL21(DE3) RPplus. Cells were grown in TB medium at
37C under shaking conditions till an O.D.600nm of 0.8. Induction was performed with 0.5 mM IPTG at 17C overnight. Cells were
collected by centrifugation at 5000 rpm for 10 minutes and stored at 20C.
METHOD DETAILS
Plasmids cloning and mutagenesis
All cloning andmutagenesis reactions were performed combining the Phusion High-Fidelity PCRMaster Mix (Thermo Scientific) with
the In-Fusion HDCloning Kit (Clontech) protocols. DNA sequences were derived from the 601Widom sequence (Lowary andWidom,
1998). A pMA vector containing 15 copies of the 147 bp 601Widom sequence was purchased fromGeneArt. DNAs were amplified in
E. coliDH5a, purified and used for nucleosome reconstitution (Luger et al., 1997). The pET3 vectors (Ampicillin resistance) containing
the sequences of the four Xenopus laevis histone proteins, were a kind gift from Dr. Toshiya Senda (Biomedicinal Information
research Center, National Institute of Industrial Science and Technology, Tokyo). H3 K4C-K23M-K27M-C110A was obtained by
two consecutive mutagenesis reactions starting from the H3 K4C-C110A already available in house. The sequence coding for human
LSD2D30 (residues 31-822) was cloned from the full-length human gene (purchased fromGeneArt) into a pJ902Express vector (DNA
2.0) with a C-terminal eGFP-His8 tag fused to a cleavable Prescission-protease cleavage site. The vector was linearized with PmeI
and inserted in the P. pastoris KM71-H strain (Invitrogen) genome through electroporation. The sequence coding for the full-length
human LSD2 was cloned in a pGEX-6P-1 vector with a GST N-terminal tag fused to a cleavable Prescission-protease cleavage site.
All LSD2 mutants were obtained from full length sequence (Figure 4). The gene for human NPAC was purchased from GeneArt and
cloned in pET24a, bearing an N-terminal Flag-His8-SUMO tag followed by Prescission protease recognition site. NPACD205 (resi-
dues 205-553) and NPAC-PWWP (residues 1-105) were obtained from the full-length construct. The pNIC28-Bsa4 vector carrying
the N-terminal His6 tagged NPAC dehydrogenase (residues 261-553) was a kind gift from Structural Genomics Consortium (SGC)
of the University of Oxford (UK).
Proteins purification
All purifications were carried out at 4C, except for the histones, DNA sequences, and NPAC dehydrogenase performed at 20C.
Chromatographic steps were performed on A¨KTA systems (GE Healthcare).
Recombinant nucleosomes were prepared according to established protocols (Luger et al., 1997). H3 mutants K4C-C110A and
K4C-K23M-K27M-C110A were alkylated with 1-methyl-1-(prop-2-ynyl)aziridinium chloride as previously described (Pilotto et al.,
2015).
LSD2D30-expressing P. pastoris cells were re-suspended in 50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 5% (v/v) glycerol, 25 mM
imidazole, 2 mg/ml DNase, and 1 mM PMSF. Zirconia beads (BioSpec products) were used to lyse the cell in a bead-beater. Then
beads were removed with aMiracloth filter paper (Merck) and the cell extract was centrifuged at 70,000 g for 30min. The supernatant
was loaded onto a His-Trap column (GE Healthcare). After a wash with 40mM imidazole, the elution was obtained with 250mM imid-
azole. The sample was supplemented with Prescission protease and dialyzed overnight in the same lysis buffer without imidazole.
The day after a second His-Trap column step was used to purify the tag-free protein at 40 mM imidazole. The sample was then gel
filtered through a Superdex 200 10/300 (GE Healthcare) equilibrated in 20 mM Tris pH 8 (25C), 100 mM NaCl, 1 mM TCEP.
LSD2 expressing E. coli BL21(DE3) cell pellets were re-suspended in 50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 5% (v/v) glycerol,
25 mM imidazole, 2% (w/v) lysozyme, and 1 mM PMSF. Cell suspension was sonicated and centrifuged at 70,000 g for 30 min.
The supernatant was loaded onto a GST-Trap column (GE Healthcare) and the tagged-protein eluted with 50 mM GSH. His-Presci-
ssion protease was added (1mg/15mL of sample). The sample was dialyzed overnight in 50mMNaH2PO4 pH 8.0, 300mMNaCl ande3 Cell Reports 27, 387–399.e1–e7, April 9, 2019
5%glycerol. After dialysis, the sample was loaded onto a secondGST-Trap to remove theGST-tag. The unbound fractions were then
loaded onto a His-Trap column to remove the His-tagged protease. A final size-exclusion chromatography step was performed on a
Superdex 200 10/300 equilibrated in 20 mM Tris pH 8 (25C), 200 mM NaCl, 1 mM TCEP.
The PWWP domain (residues 1-105) expressing cells were resuspended in 50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 5% (v/v) glyc-
erol, 1 mM PMSF and sonicated. The suspension was centrifuged at 56,000 g for 1 h and the cell extract was loaded onto a His-Trap
column. The resin was washed first with 50 mM NaH2PO4 pH 8.0, 1 M KCl, 5% (v/v) glycerol and then with 50 mM NaH2PO4 pH 8.0,
300 mM NaCl, 5% (v/v) glycerol, 50 mM imidazole. Elution was carried out in 50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 5% (v/v) glyc-
erol, 250 mM imidazole. His-tagged Prescission protease was added and the sample was dialyzed overnight in resuspension buffer.
The sample was then passed a second time through a His-Trap column, and the flow-through was collected. Finally, a Superdex 75
10/300 chromatographic step was carried out in 20 mM PIPES pH 6.5, 200 mM NaCl.
NPAC dehydrogenase cell pellet was resuspended in 50 mM HEPES pH 7.5, 500 mM NaCl, 40 mM imidazole, 5% (v/v) glycerol,
supplemented with 1 mM PMSF. The suspension was lysed by sonication and centrifuged at 70,000 g for 35 min. Cell extract was
loaded onto a 5mLHisTrap column, washed and eluted in 50mMHEPES pH 7.5, 500mMNaCl, 250mM imidazole. The sample step
was supplemented with 6xHis-TEV protease and dialyzed overnight, against 2 L of 50 mM HEPES pH 7.5, 500 mM NaCl, 5% (v/v)
glycerol. A second His-Trap column was used to remove the His-tag and TEV protease. The flow-through was loaded onto a Super-
dex 200 16/60 (GE Healthcare) in 50 mM HEPES pH 7.5, 500 mM NaCl, 5% (v/v) glycerol.
NPACD205 (linker + dehydrogenase) cell pellet was resuspended in 50mMHEPES pH 7.5, 5% (v/v) glycerol, 500mMNaCl, 40mM
imidazole, 1 mM PMSF before cell disruption by sonication and successive centrifugation at 70,000 g for 40 min. The supernatant
was loaded onto a HisTrap column and the protein was eluted by adding 250 mM imidazole. Incubation with His-tagged SUMO pro-
teasewas carried out overnight in dialysis against 50mMHEPESpH7.5, 5% (v/v) glycerol, 500mMNaCl. Both tag and proteasewere
removed through a His-Trap column. The flow through was loaded on a Superdex 200 10/300 in 50 mM HEPES pH 7.5, 5% (v/v)
glycerol, 500 mM NaCl, 0.5 mM dithiothreitol.
Enzyme activity assays
Peptides were purchased from ChinaPeptides. Activity measurements were performed with peroxidase-coupled assays on a Clar-
iostar plate reader (BMG Labtech). The reactions were carried out in 50mMHEPES pH 8.5, 0.1mMAmplex Red, 0.3mMhorseradish
peroxidase, 0.3 mM LSD2D30, with and without 3 mM NPAC-linker at different ionic strengths (0 mM NaCl, 100 mM NaCl, 150 mM
NaCl, 200 mM NaCl). H3K4me1 and H3K4me2 H3 N-terminal peptides of different lengths (1-21, 1-30, and 1-40), and H3K4me2
K23M K27M 1-40 peptide were serially diluted. Measured fluorescence signal reflects the enzymatic conversion of Amplex Red
to resorufin, as described previously (Pilotto et al., 2015). Initial velocity values were fitted to the Michaelis-Menten equation using
GraphPad Prism version 6.00 for Windows, GraphPad Software, San Diego California USA, (https://www.graphpad.com/). Inhibition
assays were performed at 100 mM NaCl using H31-40 K4me2 substrate and 100 mM putative peptide inhibitor: H2A1-19, H2A117-129,
H2B4-19, H316-40, H321-40, H41-30.
Fluorescence polarization
Wemeasured the change in polarization of a TAMRA-labeled 21-bp DNA (50-AGTCGCCAGGAACCAGTGTCA-30) through a Clarios-
tar plate reader (BMG Labtech), as previously described (Pilotto et al., 2015). Experiments were carried out in 15mMTris pH 8, 0.01%
(v/v) Tween 20 with 0-150 mM NaCl and 5 nM DNA. Peptide binding was measured as described (Pilotto et al., 2015).
Analytical size-exclusion chromatography
10 mM (final concentration) semisynthetic NCPswere incubated with 20 mMLSD2D30 and 100 mMNPAC-linker (1:2:10molar ratio) for
an hour on ice in 20 mM Tris pH 7.5, 100 mM NaCl. The mixture was loaded onto silica gel columns WTC-030N5 or WTC-030S5
(Wyatt Technology) equilibrated in 15 mM HEPES pH 7.3 (25C), 200 mM NaCl. The elution profile was recorded at 260, 280, and
400 nm.
LSD2D30 was incubated with NPACD205 and semisynthetic nucleosomes for one hour in 20 mM Tris pH 7.5, 1 mM EDTA, 1 mM
dithiothreitol, 200 mM NaCl. The mixture was loaded onto silica gel columns WTC-030N5 or WTC-030S5 (Wyatt Technology) equil-
ibrated in 15 mM HEPES pH 7.3 (25C), 200 mM NaCl. The elution profile was recorded at 214, 260, and 280 nm.
Analytical-SEC experiments of NPAC dehydrogenase were performed with Superdex 200 5/150 (Ge Healthcare) on A¨KTAmicro
system (Ge Healthcare) in buffer 50 mM HEPES pH 7.5, 100 mM NaCl, 5% (v/v) glycerol. The elution profile was recorded at 214,
260, and 280 nm.
Thermal-shift assays
Thermofluor (Biorad) experiments were carried out in duplicates in 20 mL wells containing 25 mMNPAC dehydrogenase and SYPRO
Orange (Invitrogen) 5X in 50 mM HEPES pH 7.5, 500 mM NaCl, 5% (v/v) glycerol without or with 50 mM NADH or NADPH.
HPLC-MS analysis
To avoid contamination by HEPES and reduce salt content, NPAC dehydrogenase protein was first passed through a Hi-Trap De-
salting column (GE Healthcare) at 20C in 200 mM NaCl, 25 mM Tris pH 7.5. Following a published protocol (Lu et al., 2018),Cell Reports 27, 387–399.e1–e7, April 9, 2019 e4
25 ml samples were treated with 115 ml of 40:40:20 acetonitrile:methanol:water and fresh 0.1 M formic acid, followed by addition of
10 ml of 15% (w/v) NaHCO3. Themixture was incubated at20C for 20minutes, and then the sample was centrifuged at 16,000 g for
30 min at 4C. The supernatant was analyzed by LC-MS. HPLC purification and MS experiments were performed at Centro Grandi
Strumenti (University of Pavia, Italy).
Peptide interaction assay (SPOT blot analysis)
Cellulose-bound peptide arrays were prepared using standard Fmoc solid phase peptide synthesis on a MultiPep-RSi-Spotter
(INTAVIS, Ko¨ln, Germany) according to the SPOT synthesis method provided by the manufacturer, as previously described (Lambert
et al., 2019). Human histone peptides (UniProt accession codes: P68431 (histone H3.1), P84243 (histone H3.3) and P62805 (histone
H4)) were synthesized on amino-functionalized cellulose membranes (Whatman Chromatography paper Grade 1CHR, GE Health-
care Life Sciences #3001-878) and the presence of SPOTed peptides was confirmed by ultraviolet light (UV, l = 280 nM). The assay
was performed using His6-tagged recombinant PWWP domain. Protein bound to peptides was detected using horseradish perox-
idase-conjugated anti-His antibody (dilution 1:15000, Novagene, # 71841) and the Pierce ECL Western Blotting Substrate (Thermo
Fisher Scientific, # 32106). Chemiluminescence was detected with an image reader (Fujifilm LAS-4000 ver.2.0), typically using
an incremental exposure time of 2 min for a total of 80 min. Peptide locations on the arrays and their sequences are provided in
Table S2.
Isothermal Titration Calorimetry (ITC)
Experiments were carried out on an ITC200 titration microcalorimeter from MicroCal, LLC (GE Healthcare) equipped with a Washing
module, with a cell volume of 0.2003 mL and a 40 ml microsyringe. Experiments were carried out at 15C while stirring at 1000 rpm in
ITC buffer (50 mM HEPES pH 7.5 (at 25C), 150 mM NaCl). The microsyringe was loaded with a solution of H3.11-40 peptide sample
(1605.6 mM, in ITC buffer) and was carefully inserted into the calorimetric cell which was filled with an amount of recombinant PWWP
protein (0.2 ml, 52.9 mM in ITC buffer). Following baseline equilibration an additional delay of 60 s was applied. All titrations were con-
ducted using an initial control injection of 0.3 ml followed by 38 identical injections of 1 ml with a duration of 2 s per injection and a
spacing of 120 s between injections. The titration experiments were designed as to ensure complete saturation of the proteins before
the final injection. The heats of dilution were independent of the peptide concentration and corresponded to the heat observed from
the last injection, following saturation of ligand binding, thus facilitating the estimation of the baseline of each titration from the last
injection. The collected data were corrected for peptide heats of dilution (measured in separate experiments by titrating the peptides
into ITC buffer) and deconvoluted using the MicroCal Origin software to yield enthalpies of binding and binding constants as previ-
ously described (Filippakopoulos et al., 2012). Thermodynamic parameters were calculated using the basic equation of thermody-
namics. In all cases a single binding site model, supplied with the MicroCal Origin software package was employed. Dissociation
constants and thermodynamic parameters are listed in Figure S5B.
Biolayer Interferometry (BLI)
Experiments were performed on an Octet RED384 system (Forte´Bio) at 25C in 25 mM HEPES, pH 7.5, 100 mM NaCl and 0.5 mM
TCEP and 0.01%TWEEN-20 using the Forte´Bio data acquisition software V.9.0.049. Biotinylated peptides (Alta Biosciences, Histone
Set 1-H3 library, F9: H328-48 and G1: H328-48 K36me3) were first immobilized onto Super Streptavidin biosensors (SuperStreptavidin
(SSA) Dip and Read Biosensors for kinetic #18-0011, Forte´Bio), pre-equilibrated in the BLI buffer then quenched in a solution of 5 mM
Biotin: baseline equilibration 60 s, peptide loading for 240 s, quenching for 60 s, 1000 x rpm shake speed, at 25C. The immobilized
peptides were subsequently used in association and dissociation measurements performed within a time window of 600 s (base line
equilibration 120 s, association for 240 s, dissociation for 240 s, 1000 x rpm shake speed, at 25C). PWWP concentrations (0.082,
0.24, 0.74, 2.22, 6.66, 20, and 60 mM) were used in order to determine binding constants. Interference patterns from peptide-coated
biosensors without protein were used as controls. After referencing corrections, the subtracted binding interference data were
analyzed using the Forte´Bio analysis software (Forte´Bio data analysis software V.9.0.014) provided with the instrument following
the manufacturer’s protocols.
SAXS
SEC-SAXS experiments were performed at BM29 beamline of ESRF (Grenoble, France). All samples were analyzed using Nexera
High Pressure Liquid Chromatography (HPLC; Shimadzu) system connected online to SAXS sample capillary (Brennich et al.,
2017). About 0.2-0.3 mg of sample were injected, at the flow rate of 0.25 mL/min, onto a WTC-030N5 column (Wyatt Technology)
pre-equilibrated with 15mMHEPES pH 7.3, 200mMNaCl at 20C. Scattering data were recorded using per sec frame rate on Pilatus
1 M detector located at a fixed distance of 2.87 m from the sample, allowing a global q range of 0.03–4.5 nm with a wavelength of
0.01 nm. Data analysis of collected frames, including blank subtraction and averaging, was carried out using Chromix (Panjkovich
and Svergun, 2018). Radii of gyration (Rg), molar mass estimates and distance distribution functions P(r) were computed
using both the ATSAS package (Franke et al., 2017; Konarev et al., 2004) and Scatter (Fo¨rster et al., 2010), yielding the same values
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Cryo-EM sample preparation and data acquisition
The LSD2/NPAC-linker/semi-synthetic NCP complex was obtained bymixing 20 mMof full-length LSD2with 10 mMNCP and 100 mM
NPAC-linker in 20 mM Tris pH 7.5, 100 mM NaCl. After two-hour incubation on ice, the complex was purified in buffer 20 mM Tris
pH 7.5 (4C), 200mMKCl in size-exclusion chromatography (Pilotto et al., 2015) (Figure 1D). After purification, the sample was diluted
to reach a final concentration of about 3 mM in the presence of 10 mMNPAC-linker in buffer 10mMKCl, 20mMTris pH 7.5 (4C). Holey
carbon grids (Quantifoil copper, 400 mesh, R2/1) were glow-discharged for 5 minutes before use. In a Vitrobot Mark (FEI), 4 mL of
sample were placed onto the grid, blotted for 2 s force 1 in 100% humidity at 20C, and plunged in liquid ethane.
The screening and the first evaluation datasets were collected on a 200 kV microscope (Tecnai Arctica, FEI) equipped with a
Falcon II camera (FEI) at the cryo-EM unit of the Nanyang Technological University (Singapore), and on a 300 kV microscope
(Polara, FEI) equipped with a K2 Summit (Gatan) at the Grenoble Instruct Center (Grenoble, France). The high-resolution dataset
presented in this work was collected on a 300 kV microscope (Titan Krios, FEI/Thermo Scientific) equipped with an energy filter
coupled to a K2 Summit (Gatan) at the eBIC of Diamond Light Source (Didcot, UK) with the proposal number em16082. The im-
ages were recorded at 130 kX magnification in electron counting mode, pixel size of 1.06 A˚, energy filter of 20 e- and defocus
range from 0.7 to 3.05 mm. A total of 2078 40-frames movie stacks were collected with a total dose of 50 e-A-2 in 8 s of exposure
time (1.25 e-A-2 per frame).
Image processing
All movie frames were aligned and corrected for beammotion usingMotionCor2 in dose-weighting mode (Zheng et al., 2017) and the
resulting average micrographs were processed in the framework of RELION 2.1 and 3.0 (Scheres, 2012) as specified. The integrated
images were used for CTF estimation with CTFFIND4 (Rohou and Grigorieff, 2015) followed by automated particle picking using a
Gaussian blob as reference within the RELION 2.1 workflow. A total of 490,558 particles were extracted from 1906 selected micro-
graphs with a box size of 3003 300 pixels. The extracted particles were subjected to multiple rounds of 2D classifications and low-
population or poorly-defined classes were discarded to remove junk or inconsistent particles. In parallel, an initial ab-initio density
map was separately produced by processing the same dataset using cisTEM (Grant et al., 2018). This map was used as a reference,
low-pass filtered to 40 A˚, for subsequent image processing steps carried out in RELION (Zivanov et al., 2018). The 400,624 particles
remaining after 2D classification were subjected to multiple rounds of 3D classifications in RELION 2.1 to yield five distinct classes
with resolutions ranging from 4 – 8 A˚. 3D refinements followed by local resolution filtering were performed using RELION 3.0
(Zivanov et al., 2018) to produce the final maps.
Model building and structure analysis
An initial model for the density map corresponding to the nucleosome core particle (class 1) was generated using a rigid body fit of a
crystal structure (PDB: 6ESF) in UCSFChimera (Pettersen et al., 2004). The fittedmodel was further improved bymanual rebuilding in
COOT (Emsley andCowtan, 2004). For the LSD2-nucleosome complexmaps (classes 2 and 3), the crystal structure corresponding to
the nucleosome core particle (PDB: 6ESF) was fitted followed by rigid-body docking of the crystal structure of LSD2/NPAC-linker
(PDB: 4HSU) into the additional density using UCSF Chimera (Pettersen et al., 2004). Like the nucleosome core particle, the com-
bined models of the LSD2-nucleosome complex were also subjected to manual rebuilding in COOT (Emsley and Cowtan, 2004).
The final models were validated using Molprobity (Chen et al., 2010) and EMRinger (Barad et al., 2015).
QUANTIFICATION AND STATISTICAL ANALYSIS
Activity assays
Initial velocity values were fitted to the Michaelis-Menten equation using GraphPad Prism version 6.00 for Windows, GraphPad Soft-
ware, San Diego California USA, (https://www.graphpad.com/).
Fluorescence polarization
Experiments were carried out in triplicates. Kd values were determined fitting the data to the Hill equation with GraphPad Prism
version 6.00 for Windows, GraphPad Software, San Diego California USA, (https://www.graphpad.com/).
Thermal-shift assays
Thermofluor (Biorad) experiments were carried out in triplicates. All data were analyzed using Microsoft Excel.
Domain prediction and sequence alignments
Alignments were performed with Clustal Omega tool of EMBL-EBI web platform (Li et al., 2015), and ESPrit 3 (Robert and Gouet,
2014). Sequence-based predictions were performed with ELM online software (Dinkel et al., 2016). Homologous sequences for
both LSD2 and NPAC were retrieved from Uniprot database (Bateman et al., 2017). Twenty representative sequences of
GLYR1/NPAC were selected among mammals (Ailuropoda melanoleuca, Bos taurus, Canis lupus familiaris, Equus caballus,
Homo sapiens, Loxodonta africana, Mus musculus, Oryctolagus cuniculus), amphibians (Xenopus tropicalis), reptiles (Alligator
mississippensis, Pelodiscus sinensis), birds (Gallus gallus, Taeniopygia guttata), fishes (Danio rerio, Takifugu rubripes), insectsCell Reports 27, 387–399.e1–e7, April 9, 2019 e6
(Ceratitis capitate, Noplophora glabripennis), plants (Anthurium aminicola, Arabidopsis thaliana), and chromalveolata (Symbiodi-
nium microadriaticum).
DATA AND SOFTWARE AVAILABILITY
The cryo-EMmaps and atomic coordinates have been deposited in the ElectronMicroscopy Data Bank and Protein Data Bank under
accession codes EMDataResource: EMD-4704 PDB: 6R1T (class 1), EMDataResource: EMD-4705 PDB: 6R1U (class 2),
EMDataResource: EMD-4710 PDB: 6R25 (class 3), EMDataResource: EMD-4711 (class 4), and EMDataResource: EMD-4712
(class 5). SEC-SAXS experimental data and ab-initio model have been deposited in Small Angle Scattering Biological Data Bank
with accession codes SASBDB: ASDFU3 (LSD2 D30 (31-822)), SASBDB: SASDFX3 (nucleosome), SASBDB: SASDFV3 (NPAC de-
hydrogenase (261-553)), SASBDB: SASDFW3 (NPAC D205 (206-553)), SASBDB: SASDFY3 (LSD2 (31-822)/NPAC D205 (206-553)/
nucleosome).e7 Cell Reports 27, 387–399.e1–e7, April 9, 2019
